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Introduction
Wilson’s disease is an autosomal recessive disorder of copper metabolism, and is
characterized by copper accumulation in the body. If left untreated, it can be fatal.
Copper accumulation can be observed clinically in Kayser-Fleischer Rings of the cornea,
which is a brownish-yellow ring (Gutiérrez-Ávila et al., 2014). In the liver, copper
accumulation is verified by a tissue biopsy, followed by careful copper analysis. Similar
deposits occur in the liver and brain and lead to hepatic cirrhosis and neurological
impairment (Das & Ray, 2006). The gene for the Wilson protein is called atp7b and
encodes a copper-transporting P1b-type ATPase, which is found in the liver, brain and
mammary gland. Mutations of atp7b can result in a disease state, where copper can
accumulate, lead to hepatic necrosis and copper release into the bloodstream. There are
over 300 different mutations for atp7b that can lead to this disease (Ala, Walker, Ashkan,
Dooley, & Schilsky, 2007). The N-terminus region of the Wilson protein contains six
repetitive ferrodoxin folds and each one binds to Cu(I) (Huffman & O'Halloran, 2001).
Several rare missense mutations are found in metal-binding domains 1, 5 and 6, that
cause Wilson’s disease (Bugbee, Davies, Kenney, & Cox, 2014). Metal-binding domains
5 and 6 (termed WLN5-6) are required for pumping copper across the membrane into the
lumen of the trans Golgi network, as well as copper trafficking and regulation of the
protein (Cater, Forbes, La Fontaine, Cox, & Mercer, 2004). WLN5-6 acts as a unit in
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solution and these two domains are adjacent to the first transmembrane (Achila et al.,
2006) helix of Wilson protein. An NMR titration was performed by adding the
metallochaperone Cu(I)-HAH1 to WLN5-6, and showed that copper did not transfer
between the two proteins. However, when metal-binding domain 4 (WLN4) was
combined with WLN5-6, copper was transferred from WLN4 to WLN5-6. When Cu(I)HAH1 was added either to WLN4 or WLN2, an NMR-observable complex did form.
Therefore, WLN2 or WLN4 acquire Cu(I) first and then route copper to WLN 5-6, before
the ATPase can transport copper across the vesicular membrane (Achila et al., 2006).
WLN6 is required for activity of the Wilson protein, as demonstrated from
complementation assays in yeast (Cater et al., 2004). The figure below shows the threedimensional NMR structure of WLN5-6 (PDB ID 2EW9) (Huffman & Hinz, 2013).

Figure 1. This figure shows the 3-D NMR structure of WLN5-6 (figure reproduced with permission from
Huffman and Hinz 2013).
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Mutations can impair copper trafficking, which will cause a defective biliary
excretion of copper (Payne, Kelly, & Gitlin, 1998). Copper trafficking is defined as the
movement of the Wilson protein from the trans Golgi network to a vesicle near apical
canicular membrane as a function of apparent cellular copper concentrations. A higher
than normal cellular concentration of copper in the cytosol should lead to the trafficking
of the Wilson protein to apical canicular membrane and eventual expulsion into the bile.
Wilson disease mutations can impair translocation of copper and lead to an accumulation
of copper in the cytosol of hepatocytes (Cater et al., 2004). Excess copper may be
released into the bloodstream if the concentration exceeds the chelation capacity of the
cell.
In the cell copper normally exists as Cu(I), but in excess (as in Wilson disease)
the copper can disproportionate into Cu(0) and Copper(II). This can lead to copper
deposition in the cell in the case of Cu(0). In the case of Cu(II), the pKa of H2O can be
lowered, activating adventitious hydrolytic chemistry (Huffman & Hinz, 2013). The
frequency of Wilson disease is one in 35,000 people worldwide (Wilson Disease, 2009).
This disease has clinical heterogeneity with non-specific symptoms, which makes the
diagnosis very difficult.
Proper copper homeostasis is necessary to sustain life (Lutsenko & Cooper,
1998). The CTR permeases, copper chaperones, and the copper-transporting P1b-type
ATPases act together to control copper homeostasis (Huffman & O'Halloran, 2001).
Wilson protein, a copper-transporting P1b-type ATPase, is normally located in the trans
Golgi network, and pumps copper across the membrane to incorporate copper into
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enzymes like ceruloplasmin. Ceruloplasmin (Scheinberg & Gitlin, 1952) is an enzyme
that is essential for iron uptake (Hellman & Gitlin, 2002).
The figure below indicates several fates for Cu(I) after entry into a cell, including
its movement to Cu/Zn-SOD1 for free radical detoxification, to the mitochondria for
incorporation into components of the electron transport chain, to metallothionein for
sequestration, or to the trans Golgi for incorporation into apoproteins. Alternately, excess
Cu(I) can also be pumped out of the cell by the P1b-type ATPases, i.e. the Wilson or
Menkes protein (Huffman & Hinz, 2013).

Figure 2. This figure shows the pathway of Cu(I) (blue spheres) movement in the cell. It also shows the
Wilson protein as ATP7b, which contains WLN5-6 (figure reproduced with permission from Huffman and
Hinz 2013). Note that copper stores are also located in the mitochondrion.
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Experimental Objectives
The purpose of this study was to develop a fusion protein expression system for
WLN 5-6 that allowed high-level expression of WLN 5-6. The fusion protein (Figure 3)
began with Thioredoxin, followed by a HisTag, then the sequence ENLYFQG (a TEV
protease site), followed by WLN 5-6. The fusion protein should give high-level
expression of WLN5-6 even in the presence of unstable mutants.
MSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQGKLT
VAKLNIDQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLA
GSGSGHMHHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTGGGSGIEGR
ENLYFQGMAPQKCFLQIKGMTCASCVSNIERNLQKEAGVLSVLVALMAGKAEIK
YDPEVIQPLEIAQFIQDLGFEAAVMEDYAGSDGNIELTITGMTCASCVHNIESKLT
RTNGITYASVALATSKALVKFDPEIIGPRDIIKIIEEIGFHASLAQ
Figure 3. The blue letters represent Thioredoxin; the underscore represents the HisTag; the red letters
represent the TEV Protease site; and the green letters represent the WLN5-6.

Materials and Preparation
Template DNA and Primers
A template encoding all six metal-binding domains of atp7b were used, prepared by Dr.
Joshua Muia (Muia, 2010), pET32Xa/LIC-WLN1-6. Mutagenic primers were design to
amplify the portion of the gene containing WLN5-6 as well as to incorporate a TEV
protease site directly upstream of the WLN5-6 gene, into the commercial vector pET32Xa/LIC. Therefore the primers also included sequences specific for the ligation
independent cloning (LIC) method. A 200 µM stock solution of each primer was
prepared and then each were diluted to 10mM. The forward primer was 5’-GGT ATT
GAG GGT CGC GAG AAC CTT TAT TTC CAG GGC ATG GCA CCG CAG AAG
TGC TTC-3’ and the reverse primer was 5’-AGA GGA GAG TTA GAG CCT CAC
TGG GCC AGG GAA GCA TGA AAG CCA ATT TCC-3’. The portion of the forward
!
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primer encoding the TEV sequence is underlined. These primers were synthesized by
Integrated DNA Technologies (Coralville, IA).
PCR Reaction Conditions
Amount added

KOD Hot Start DNA Polymerase ingredients

5 µL

10X supplied Buffer

3 µL

25 mM MgSO4

5 µL

dNTPs

32 µL

supplied water

1.5 µL

Forward primer

1.5 µL

Reverse primer

1 µL

Template DNA

1 µL

KOD Hot Start DNA Polymerase (1U/µL)

50 µL

Total solution

Table 1. This table shows the amount of materials added together for KOD Hot Start DNA Polymerase.

PCR was performed using KOD Hot Start DNA Polymerase (EMD Millipore #71086)
following manufacturers recommended protocol (Bulletin TB341) using a heated lid at
110°C.
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PCR Steps

Time

1. Denaturation & polymerase activation at 95°C

2 minutes

2. Denaturing at 95°C

20 seconds

3. Annealing at 65°C & 70°C (two separate reactions)

10 seconds

4. Extension at 70°C

15 seconds

Steps 2-4 repeated for 30 cycles
Table 2. This table shows the conditions used to complete the KOD Hot Start DNA Polymerase reaction.

Agarose Gel Electrophoresis
30 mL of the 10X TAE buffer was combined with 270 mL of milliQ water (doubly
distilled RO water was used for all experiments) to make a 300 mL of 1X TAE buffer.
0.320 g of agarose (AMRESCO #0710-100G) was placed into 40 mL of the 1X TAE
buffer and heated in a microwave oven for 1 minute and 20 seconds. 2 µL of ethidium
bromide (100 µg/mL) was added to this mixture for subsequent visualization under UV
light. The solution was poured into a casting apparatus including a comb and was allowed
to set for 30 minutes to form a gel. The gel was carefully removed from the cast and
placed in the electrophoresis unit so that the wells were closest to the negative electrode
and the gel was covered the 1X TAE Buffer. 5 µL (~200 ng) of one of the PCR products
was combined with 1 µL of the gel loading dye (6X), then added to the well. The 1 kb
DNA ladder (NEB #3232) was prepared by combining 1 µL of the ladder, 4 µL of water
and 1 µL of the dye. The remaining buffer solution was poured into the side wells, and
covered the gel. The agarose gel electrophoresis was run for 41 minutes at 120 V and
visualized under UV light.
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PCR Purification Preparation
To purify the PCR product, the QIA quick PCR Purification Kit (Qiagen #28104) was
used. A summary of the procedure follows. 24 mL of ethanol was added into buffer PE to
make a total solution of 30 mL. 225 µL of buffer PB was added to 45 µL (~1800 ng) of
each PCR product, to create a 5:1 ratio of buffer PB to PCR product, and mixed. Each
solution was centrifuged in the 2 mL QIA quick collection tubes for 1 minute at 13000
rpm. After that, the flow through was discarded and the column was put back into the
same tube. Then, 750 µL of buffer PE was added to each column to wash the PCR
product. Each tube was centrifuged for 1 minute at 13000 rpm and the waste was
discarded. The tubes were centrifuged for 1 additional minute to remove any additional
residual wash. Then the QIA quick column was placed into a 1.5 mL microcentrifuge
tube and the waste was discarded. 30 µL of elution buffer (EB) was added to the center of
the QIA quick membrane. The column stood for 1 minute and then was centrifuged for 1
minute. The eluent was collected, since it contained the purified PCR product.
LB Agar Plates with Ampicillin
LB agar plates were prepared with 100 µg/mL ampicillin. The LB agar was made by
adding 20 grams of the LB agar into 500 mL of water in an Erlenmeyer flask. This was
autoclaved for 1 hour and 30 minutes. After cooling to 52°C, the appropriate amount of
ampicillin was added and the agar was poured into plates.
pET32Xa/LIC Cloning Procedure
The pET-32 Xa/LIC Vector Kit (EMD Millipore #70072) procedure was followed to
clone my insert containing the gene for WLN5-6 into the fusion vector. I used 1.6 µL
(~15 ng) of the purified PCR product , 13 µL of nuclease-free water, 2 µL of the 10X T4

!

8!

Sandra Weitzner Honor’s Thesis

DNA Polymerase buffer, 2 µL of the 25 mM dGTP, 1 µL of the 100 mM DTT and 0.4 µL
of 2.5 U/µL of LIC-qualified T4 DNA Polymerase to make a total solution of 20 µL. This
was added into a 0.5 mL microcentrifuge tube and the enzyme was added last in order to
start the reaction. The reaction will remove all bases until a ‘G’ is reached, using the 3’-5’
exonuclease activity of the polymerase, creating a long 15-17 bp overhang. This reaction
was incubated it at 22°C for 30 minutes and then the enzyme was inactivated by
incubating it at 75°C for 20 minutes. The overhangs of the insert now will match those in
the pET-32 Xa/LIC vector supplied in the kit. 1 µL of the pET-32 Xa/LIC vector (50 ng)
and 2 µL (~1.5 ng) of the polymerase treated product were added together into a 0.5 mL
microcentrifuge tube. This was incubated for 5 minutes at 22°C. Then, 1 µL of 25 mM
EDTA was added to make a total volume of 4 µL. The solution was mixed, by stirring
with a pipette tip. Then the tube was incubated for 5 minutes at 22°C in the PCR
machine. A transformation was then performed. 10 µL of the Nova Blue GigaSingles®
competent cells (EMD Millipore) from the stock tube were combined with 1.5 µL of the
insert/vector complex into a 0.5 mL microcentrifuge tube. Then, the components were
stirred with a pipette tip. The tube was incubated on ice for 5 minutes, heated at 42°C for
20 seconds (heat shock), and incubated on ice for 2 additional minutes. 250 µL of LB was
added to the tube and incubated while spinning and shaking at 37°C for 1 hour. The cells
were plated on LB ampicillin plates and allowed to grow for 16 hours at 37°C. A single
colony from the plate above was inoculated into a tube with 4 mL of LB/Amp (100
µg/mL). 6 colonies were harvested in this way and incubated overnight with shaking at
37°C. The resultant cultures were centrifuged and the pellets were stored at -20°C, after
careful removal of supernatant.
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Recombinant Plasmid Purification
The QIAprep Spin Miniprep Kit (Quiagen #27104) was used to purify plasmids. The
pelleted bacterial cells from a 4 mL culture (above) were suspended in 250µL of Buffer
P1. 250 µL of Buffer P2 was added to the tube and mixed thoroughly by inverting 4-6
times. Then, 350 µL of Buffer N3 was added and mixed immediately and thoroughly by
inverting 4-6 times. Each tube was centrifuged for 10 minutes at 13000 rpm to form a
pellet. Then, the supernatants from the last step were poured into the QIAPrep Spin
Column. This was centrifuged for 60 seconds and the flow-through was discarded.
Afterwards, 0.5 mL of Buffer PB was added to wash the column and was centrifuged for
60 seconds and the flow-through was discarded. The column was washed by adding 0.75
mL of Buffer PE, centrifuging for 60 seconds, and discarding the flow-through. It was
centrifuged for an additional minute to remove the residual wash and the QIAPrep
Column was placed into a 1.5 mL microcentrifuge tube. 50 µL of Buffer EB was added to
the center of each QIAPrep Spin Column. This stood for 1 minute and was centrifuged
for 1 minute, and then the eluent was collected.
Restriction Mapping of Recombinant Plasmids
After the recombinant plasmid was purified, a double digestion was performed. 5µL (~1
µg) of plasmid was added to a 1.5mL microcentrifuge tube with 1 µL BamHI (20 U/, µL)
2µL of BglII(10U/ µL), 0.2µL of BSA (100x), 2µL of 10X Buffer 3 (NEB) and 9.8µL of
milliQ water. Single digests were also performed with only one enzyme present (Table
3). This mixture incubated for 3 hours in the 37°C incubator. Agarose gel electrophoresis
was done after the digestion, by adding 10 µL of sample with 2µL of 6x loading dye and
visualized as above.
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Contents

Single BamHI digestion

Single BglII digestion Double digestion

Plasmid

4 µL

4 µL

4 µL

BamHI

1 µL

0 µL

1 µL

BglII

0 µL

2 µL

2 µL

Buffer 3

0 µL

0 µL

2 µL

BamHI buffer

2 µL

0 µL

0 µL

BSA

.2 µL

.2 µL

.2 µL

Water

12.8 µL

13.8 µL

10.8 µL

Total

20 µL

20 µL

20 µL

Table 3. This table shows the mixture used for the digestion using the enzymes BamHI and BglII.

Gel Extraction of DNA
Initial cloning results did not give an insert of the correct size (543 bp) after restriction
mapping with BamHI and BglII, therefore the PCR product was cut out of the agarose gel
and purified. In order to do this, the agarose gel was overloaded with about 30µL (~900
ng) of the PCR product spread across two lanes from two different annealing
temperatures, 65°C and 70°C. To extract the DNA, the QIAQuick Gel Extraction Kit
(Qiagen # 28704) was used. The DNA fragment was excised from the agarose gel with a
clean razor, by looking at it under long wavelength UV light. Then the gel slices were
weighed in a colorless previously tared tube. I added 3 volumes of Buffer QG to 1
volume of gel. Then this was incubated at 42 °C for 10 minutes and was inverted every 23 minutes during incubation. Then 1 gel volume of isopropanol was added to the sample
and mixed. Also, a QIA Quick Spin Column was used with a 2 mL collection tube, and
the sample was applied to the column. Then it was centrifuged for 1 minute and the flow
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through was discarded. Then, 0.5 mL of buffer QG was added, it was centrifuged for 1
minute and the flow through was discarded. Also, 0.75 mL of Buffer PE was added to
wash the column, it was centrifuged for 1 minute, and the flow through was discarded.
Then it was centrifuged for an additional minute and the flow through was discarded.
Afterwards, the column was placed into a 1.5 mL microcentrifuge tube and 30µL of
buffer EB was added to the center of the QIA Quick membrane. Then it sat for 1 minute
and was centrifuged for 1 minute. The eluent was collected.
Buffer Preparation
An equilibration and an elution buffer were prepared. For the equilibration buffer, 250
mL of 50 mM HEPES, 500 mM NaCl, and 30 mM Imidazole was prepared and the pH
was adjusted to be 7.46. For the elution buffer, 250 mL of 50 mM HEPES, 500 mM
NaCl, and 300 mM Imidazole was prepared and the pH was adjusted to be 7.54. The Tris
buffer was prepared with 50 mM Tris base, 1 mM DTT, and 0.5 mM EDTA buffer and
pH was adjusted to be 7.97.
TRX-WLN5-6 Protein Expression
The recombinant plasmid used for protein expression was called pET32Xa-TEV-WLN56 and was sequenced at Retrogen (San Diego, CA). 1 µL of plasmid (~20 ng) was
transformed into competent BL21(DE3) cells, plated on LB/Amp, then incubated for 1216 hours. A single colony was inoculated into 5 mL of LB/Amp (100 µg/mL) and
incubated with shaking for 5.5 hours at 37°C. Then it was added to 100 mL of LB/AMP
(100 µg/mL) and incubated at 37°C incubator with shaking. After the OD reached 0.65,
IPTG was added to make a final concentration of 1 mM. The absorbance or optical
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density (OD) of the 100 mL LB broth was measured at different time intervals as shown
below.
Time of OD measurement

Optical Density

30 minutes after addition of IPTG

0.18

55 minutes after

0.26

75 minutes after

0.47

95 minutes after

0.65

Table 4. This table shows the results of the measurements of the optical density after IPTG was added for
the product, pET32Xa-TEV-WLN5-6.

After 2.5 hours, the culture was harvested by centrifugation and the resulting pellet was
stored at -20°C.
TRX-WLN5-6 Protein Extraction
The pellets were removed from the tubes and weighed in a preweighed Falcon tube. The
pellet weighed 0.277 grams. Then, two buffers were prepared as stated above; the
equilibration buffer and the elution buffer were filtered through a 0.22 µm filter to
remove any impurities. The bacterial pellet containing the protein was thawed and frozen
a few times using liquid nitrogen to permeabilize the cell membrane. BugBuster® Protein
Extraction Reagent (EMD Millipore #70854), 5 mL/g pellet, was added to break the cells
open. 0.2 µL of 250U/µL of benzonase (Sigma #E8263) was added, and it was slowly
agitated at room temperature for 20 minutes. 1 mL of the solution was added to two 1.5
mL microcentrifuge tubes and they were centrifuged at 14500 rpm for 2 minutes.
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TRX-WLN5-6 Protein Purification and Digestion
A 1 mL HisTrap column (GE Healthcare # 29-0510-21) was washed, by adding 10 mL of
the elution buffer and 15 mL of the equilibration buffer. The protein-containing solution
(~1 mL) was loaded into the HisTrap column and then the column was washed, by 10 mL
equilibration buffer, and then the protein was eluted by adding 15 mL elution buffer.
Then the buffer was exchanged with a 5 mL HiTrap desalting column (GE Healthcare #
17-1408-01). First, the desalting column was cleaned with 25 mL of the Tris buffer and
then 1.5mL of the protein-containing solution was loaded into the column. Afterwards,
the Tris buffer was used to elute the column, and 2 mL fractions were collected. To the
2mL fraction containing the protein of interest, TEV protease was added and the solution
was left overnight at room temperature.
Purification of TRX-WLN5-6 Digest
A 1 mL HisTrap column (GE Healthcare # 29-0510-21) was cleaned with 7 mL of
elution buffer and 10 mL of equilibration buffer. The sample was loaded onto the
HisTrap column and the protein was eluted with 6 mL of the equilibration buffer and the
solution that flowed out of the column was collected. A 15% SDS-PAGE was performed
for the protein. RPN800E (GE Healthcare), which is a full-range molecular weight
marker, was used as the ladder. 5 µL of RPN800E was added to the first lane in the gel.
Lane 2 contained non-induced cells. A solution of the pellet 2.5 hours after IPTG was
loaded onto lane 3. To the fourth well in the gel, 20 µL of the extracted protein was
added. To the fifth well in the gel, 20 µL of the undigested solution after HisTrap was
added. To the sixth well, 20 µL of the solution after digestion was added. To the last well,
20 µL of the solution was added after it was digested and run through the HisTrap again.
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Results
Originally, when the gene containing WLN5-6 was amplified a lower annealing
temperature of 55°C was used (Figure 4), but subsequent cloning gave an insert of the
wrong size (Figure 5). Therefore the annealing temperature was increased to 70°C
(Figure 6).
!!!!!!!!!!!!!!!!!!!!!!!!!!Lanes!
!!!!1
2
3

500 bp

Figure 4. 1.5% Agarose gel electrophoresis results of the two original PCR products with an annealing
temperature of 55°C, before it was purified.
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1

2

3

4

6000 bp
1700 bp

Figure 5. 1.5% Agarose gel of a BamHI/BglII double digest of the initial recombinant plasmid, produced
from a PCR product using an annealing temperature of 55°C. The gel shows bands at 6000 bp and 1700 bp,
which is not the band that was expected at 543 bp.

1

2

3

1000 bp
500 bp

Figure 6. 1.5% Agarose gel of PCR using higher annealing temperatures. Lane 2 contains the PCR product
with a 65 °C annealing temperature. Lane 3 contained the PCR product with an annealing temperature of
70 °C. There is band at 500 bp, but there is also a faint band at 1000 bp, so the DNA was excised in order
to only have the product band be at 500 bp.

In order to obtain a pure product, a gel extraction was performed using the QIAQuick Gel
Extraction Kit. A gel was run and observed under a UV light. The results of the gel
electrophoresis are shown in Figure 7.
!
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! 1

2

3

4

5

500 bp

Figure 7. This figure shows the gel after the DNA was excised at 500 bp. A gel was run after excision to
make sure there was actually product in the area that the gel was removed from.

After extraction, a gel was run and a band that was only at 500 bp could be seen in the
gel, which meant it was purified enough. The results of the gel electrophoresis are shown
in Figure 8.

!!!! 1

2

3

500 bp

Figure 8. This figure shows the gel after the QIA Quick Gel Extraction Kit was used to extract the gel. This
shows a clearer product in the gel and there is no longer a band at 1000 bp. The research proceeded using
the product in well 3, because it was the product obtained from an annealing temperature of 70°C.

The product with the higher annealing temperature was chosen, because it had a clearer
band at 500 bp, and this was used to proceed with the cloning process. The pET-Xa/LIC
cloning procedure was followed to insert this product into the vector. The recombinant
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vector was purified and a double digest was performed with BamHI and BglII, resulting
in fragments of the correct size (Figure 9).
! 1

2

3

6000 bp

500 bp

Figure 9. 1.5% agarose gell. Lane 2, BamHI/BglII digest of pET32Xa-TEV-WLN5-6. Lane 3, undigested
vector.

The new recombinant vector was sequenced to confirm its validity and then transformed
into BL21(DE3) and plated onto LB/Amp. Single colonies from the plate were inoculated
into 5 mL LB/Amp, and then transferred to a 100 mL LB/Amp vial. After an OD of 0.65,
the culture was induced with IPTG. After 2.5 hours, the culture was centrifuged and the
pellet was collected. BugBuster® Protein Extraction Reagent (EMD Millipore) was used
to break down the cell containing the product, and HisTrap chromatography was used to
purify it. Also, a HiTrap column was used for buffer exchange and desalting. TEV
protease was added to remove the fusion protein. Purification by HisTrap
chromatography was repeated to separate the HisTag containing the fusion protein from
the WLN 5-6 protein. 15% SDS-PAGE was run and the product could be seen on the gel
(Figure 10), which matched the results from sequencing. WLN5-6 can be seen in lane 6,
which indicated the molecular weight was 16 kDA. In lane 7, the protein had been diluted
and the band was too faint to observe scanning the gel.
!
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1

2

3

4

5

6

7

16 kDa

Figure 10. 15% SDS-PAGE. Lane 1 is the RPN800E (GE Healthcare) ladder; lane 2 is before the addition
of the IPTG; lane 3 is the induction after addition of IPTG; lane 4 is after extraction with Bugbuster®, lane
5 is the undigested product after HisTrap, lane 6 is after digestion using TEV, and lane 7 is after the final
HisTrap step. The band in well 7 is too faint too observe.

Discussion:
High-level expression of WLN5-6 was demonstrated when co-expressed with a
fusion protein containing a cleavage site for TEV protease. Future work will entail
incorporating mutations into this construct that are difficult to express in a non-fusion
construct. Hopefully, this will further the understanding of disease-causing mutants of
Human Wilson Protein. Several disease-causing missense mutations are located in
WLN5-6 (Bugbee et al., 2014) and WLN5-6 is also required for transport of copper by
the Human Wilson protein.
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